secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001558370-23-015711
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma receives Nasdaq delisting notice; stock moves to OTC Pink
---------------------------------------------------------------------------

- Received formal notice on Sept 12, 2023 for failure to comply with Nasdaq Listing Rule 5550(b)(1).
- Trading on Nasdaq Capital Market suspended effective Sept 14, 2023.
- Common stock will trade on OTC Pink Sheets under ticker KRBP starting Sept 14.
- Company will pursue uplisting to OTCQB but no assurance of market development.
- Delisting not expected to impact day-to-day operations, per company statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/0001558370-23-015711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/krbp-20230912x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer